Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00078572
Status:
COMPLETED
Last Update Posted:
2010-12-13
First Post:
2004-03-01
Brief Title:
Capecitabine XELODA With Or Without Lapatinib GW572016 For Women With Refractory Advanced or Metastatic Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
100151
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
ED Derilus Clinical Disclosure Advisor
Old Organization:
GSK Clinical Disclosure